Steven McAllister to become chief financial officer for InVivo therapeutics


Steven McAllister will take up the role of interim chief financial officer on 31st December, replacing Gregory Perry (who is leaving the company on December 30 to join another local biotechnology company). McAllister served as vice president, finance and administration for Biomet Spine and Bone Healing Technologies from 2007 to 2013.

Michael Astrue, InVivo’s interim chief executive officer, said, “Steve McAllister brings expertise in both finance and in the operations of device companies. I am confident that he will provide the same judgment, integrity and strategic vision provided by Greg Perry during our initial repositioning of InVivo.”